Detalhe da pesquisa
1.
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
Cell
; 149(6): 1284-97, 2012 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22632761
2.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697469
3.
Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis.
Eur J Haematol
; 111(6): 888-894, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640495
4.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 196(1): 136-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496035
5.
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Br J Haematol
; 193(4): 779-791, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876423
6.
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.
Br J Haematol
; 192(4): 729-736, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588428
7.
Human Multipotent Stromal Cell Secreted Effectors Accelerate Islet Regeneration.
Stem Cells
; 37(4): 516-528, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674070
8.
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Eur J Haematol
; 103(3): 178-189, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177553
9.
Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.
Support Care Cancer
; 26(7): 2379-2386, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423678
10.
Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor.
Ann Hematol
; 101(6): 1373-1374, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106640
11.
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Biol Blood Marrow Transplant
; 22(4): 763-767, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643030
12.
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Biol Blood Marrow Transplant
; 20(11): 1813-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042735
13.
Merkel cell carcinoma mimicking acute leukemia.
Int J Lab Hematol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477102
14.
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study.
Clin Lymphoma Myeloma Leuk
; 24(5): 305-315, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336492
15.
Identification of cells of leukemic stem cell origin with non-canonical regenerative properties.
Cell Rep Med
; 5(4): 101485, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582086
16.
Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Blood
; 117(26): 7112-20, 2011 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562049
17.
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.
Nat Med
; 12(1): 89-98, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16341242
18.
Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantation.
J Clin Apher
; 28(4): 285-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23426584
19.
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure.
Transplant Cell Ther
; 29(2): 120.e1-120.e9, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460202
20.
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.
Bone Marrow Transplant
; 58(9): 1024-1032, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365296